Search - tctmd.com

Displaying 1 - 20 of 69

Sort: Relevancy | Date

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Akhilesh Sista

October 30, 2024

Presentation TCT 2024

Clinical Trial Update in 2024

Presenter: Jay Giri

October 30, 2024

Presentation TCT 2024

Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial

Presenter: Wissam Jaber

October 29, 2024

Presentation TCT 2024

What am I Most Anticipating in Upcoming Clinical Trials?

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

Presenter: Behnood Bikdeli

October 29, 2024

Presentation TCT 2024

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Presenter: Aakriti Gupta

October 28, 2024

Presentation TCT 2024

Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention?

Presenter: Suresh Vedantham

October 28, 2024

Presentation TCT 2024

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Presenter: David Kandzari

October 28, 2024

Presentation TCT 2024

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Presenter: Seung-Jun Lee

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2023

Update from the PROTECT H2H Trial with Emboliner (Case Example)

Presenter: Amit Vora

October 26, 2023

Presentation TCT 2023

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

Presenter: Ajay Kirtane

October 26, 2023

Presentation TCT 2023

TCT 296: Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis of the FAUST and UNIVERSAL Trials

Presenter: Sanjit Jolly

October 26, 2023

Presentation TCT 2023

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

Presenter: Daniel Burkhoff

October 25, 2023

Presentation TCT 2023

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Presenter: David Kandzari

October 25, 2023

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Presenter: Ajay Kirtane

October 25, 2023

Advertisement

Clinical Trial Update in 2024

Clinical Trial Update in 2024

Large-bore Mechanical Thrombectomy vs Catheter-directed Thrombolysis for Treatment of Intermediate-Risk Pulmonary Embolism: Primary Outcomes From the PEERLESS Randomized Controlled Trial

What am I Most Anticipating in Upcoming Clinical Trials?

Most Important Clinical Trial Endpoints to the PE Clinician in the Trenches

A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices

Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention?

Long-term Safety and Efficacy of Radiofrequency Renal Denervation in the Presence of Antihypertensive Drugs: 24-Month Results From the SPYRAL HTN-ON MED Randomized Trial

Intravascular Ultrasound-Guided Versus Angiography-Guided Drug-Coated Balloon Angioplasty in Complex Femoropopliteal Artery Disease: Primary Subgroup Analysis of the Randomized IVUS-DCB Trial

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Update from the PROTECT H2H Trial with Emboliner (Case Example)

Individual Patient-data Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure at 6 Months in the RADIANCE Clinical Trial Program

TCT 296: Ultrasound-Guided Transfemoral Access for Coronary Procedures: A Pooled Learning Curve Analysis of the FAUST and UNIVERSAL Trials

Backbeat Clinical Trial Program (Pacemaker-Mediated Blood Pressure Lowering)

IBERIS Clinical Trial Program (Radio-Frequency Renal Denervation)

TARGET Clinical Trial Program (Alcohol-Mediated Renal Denervation)

SYMAP Clinical Trial Program (Radio-Frequency Renal Denervation)

SPYRAL Clinical Trial Program (Radio-Frequency Renal Denervation)

Exemplary Cases From the LIFE-BTK Trial

RADIANCE Clinical Trial Program (Ultrasound Renal Denervation)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content